Clinical trial Recruiting at 1 site Interventional Ages 18 to 50

Using dexmedetomidine to reduce agitation after nasal surgery

Official title: Effectiveness of Single Bolus Versus Continuous Infusion of Dexmedetomidine in Mitigating Agitation in Adults Undergoing Nasal Surgery: a Prospective Randomized Trial

Run by Fayoum University Hospital · NCT06867302 · Data updated 2026-11-12

This study is testing whether giving a single dose of dexmedetomidine can help reduce agitation in obese adults after nasal surgery compared to a continuous drip of the medication.

Quick facts

Study typeInterventional
Ages18 Years to 50 Years
SexAll
Enrollment50 (estimated)
SponsorFayoum University Hospital
Academic / other
Locations1 site (Al Fayyum, Faiyum Governorate)
StatusRecruiting
StartedAugust 1, 2025
Main results expectedNovember 1, 2026
Study endsDecember 1, 2026
Registry record updatedSeptember 30, 2026
Trial IDNCT06867302 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are obese adults with a BMI under 30 who are undergoing elective nasal surgery.

Probably not a fit

Patients with significant comorbidities, cognitive dysfunction, or those requiring intensive care post-surgery may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to compare the effectiveness of a single bolus dose of dexmedetomidine versus a continuous infusion in reducing emergence agitation in obese adults undergoing nasal surgery. Emergence agitation can lead to serious complications, including self-injury and increased medical attention. The study focuses on adults, particularly those with risk factors such as obesity and ENT surgery, to evaluate how dexmedetomidine can mitigate these risks. Participants will receive dexmedetomidine in a saline solution before extubation to assess its impact on agitation levels.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the incidence of emergence agitation, leading to safer recovery and less need for additional medical interventions.

How similar studies have gone: While there have been studies on dexmedetomidine in pediatric populations, this approach in adults, particularly for nasal surgery, is less explored and may provide novel insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* American Society of Anesthesiologist (ASA) Ⅰ or II
* Adults with body mass index (BMI) \< 30 Kg/m
* Underwent elective nasal surgery.

Exclusion Criteria:

* Significant comorbidity like hepatic, renal, or cardiac disease
* Auditory impairment
* Cognitive dysfunction
* Substance abuse
* Allergy to the studied medicines
* Planned intensive care admission after the surgery.

Where it's running

  • Fayoum University Hospital
    Al Fayyum, Faiyum Governorate, Egypt
    Recruiting

Study contacts

  • Principal investigator: Yasser S Mostafa, MD — Fayoum University
  • Study coordinator: Yasser S Mostafa, MD
  • Email: ysm03@fayoum.edu.eg
  • Phone: 01010509735

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.